These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 5598902)
41. [Animal experimental studies of the effect of synthetic antifibrinolytics]. Markwardt F; Klöcking HP Acta Biol Med Ger; 1966; 17(6):746-54. PubMed ID: 5990894 [No Abstract] [Full Text] [Related]
42. [Comparative studies on antifibrinolytic agents]. Landmann H Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):106-12. PubMed ID: 4173870 [No Abstract] [Full Text] [Related]
43. Comparative activities of amino acid and polypeptide inhibitors on natural and synthetic substrates. Skoza L; Tse AO; Semar M; Johnson AJ Ann N Y Acad Sci; 1968 Jun; 146(2):659-72. PubMed ID: 4239440 [No Abstract] [Full Text] [Related]
45. [Comparison of antifibrinolytic effects of epsilon-aminocaproic acid and enzyme inhibitors in the surgery of portal hypertension]. Lande M; Clot-Paimboeuf C; Dentan T Presse Med (1893); 1971 Jan; 79(1):15-6. PubMed ID: 5539954 [No Abstract] [Full Text] [Related]
46. [The inhibitors of fibrinolysis: new information on antifibrinolytic agents]. Giacomazzi G Haematologica; 1968; 53(7):489-533. PubMed ID: 4976851 [No Abstract] [Full Text] [Related]
47. [On the antifibrinolytic activity of the esters of 4-aminomethylbenzoic acid (PAMBA)]. Markwardt F; Neuland P; Klöcking HP Pharmazie; 1966 Jun; 21(6):345-8. PubMed ID: 6000982 [No Abstract] [Full Text] [Related]
48. Investigation and determination of the antifibrinolytic properties of dipeptides and synthetic compounds. Dupin JP; Boisseau M; Brasington RD; Mesnard P Pathol Biol (Paris); 1978; 26(5):233-9. PubMed ID: 358100 [TBL] [Abstract][Full Text] [Related]
49. Omega-amino acids and various biogenic amines as antagonists to pentylenetetrazol. Kobrin S; Seifter J J Pharmacol Exp Ther; 1966 Dec; 154(3):646-51. PubMed ID: 5928260 [No Abstract] [Full Text] [Related]
50. Studies on fibrinolytic enzymes in the field of obstetrics and gynecology, especially tissue activator. 4. Antifibrinolytic action of sex hormones, especially a conjugated estrogen (Premarin) and its application. Mori N; Takemoto J Acta Obstet Gynaecol Jpn; 1969 Jul; 16(3):137-42. PubMed ID: 4309742 [No Abstract] [Full Text] [Related]
51. [Antifibrinolytic effect of araliphatic esters and amides of p-aminomethylbenzoic acid]. Klöcking HP; Knauer H; Markwardt F Acta Biol Med Ger; 1973; 30(3):Suppl:K9-13. PubMed ID: 4762328 [No Abstract] [Full Text] [Related]
52. Synthetic inhibitors of fibrinolysis: in vitro and in vivo mode of action. Okamoto S; Oshiba S; Mihara H; Okamoto U Ann N Y Acad Sci; 1968 Jun; 146(2):414-29. PubMed ID: 5254270 [No Abstract] [Full Text] [Related]
53. Bridged bicyclic and polycyclic amino acids. Potent new inhibitors of the fibrinolytic process. Loeffler LJ; Britcher SF; Baumgarten W J Med Chem; 1970 Sep; 13(5):926-35. PubMed ID: 5458384 [No Abstract] [Full Text] [Related]
54. [Activity of antifibrinolytics when administered using a direct current]. Krylov IuF; Loginova VA; Efanov OI Farmakol Toksikol; 1978; 41(1):80-2. PubMed ID: 304816 [TBL] [Abstract][Full Text] [Related]
56. [Complexes of heparin with antiplasmins and several of their properties]. Pastorova VE; Kudrashov BA; Rodina VI Vopr Med Khim; 1973; 19(5):492-7. PubMed ID: 4788172 [No Abstract] [Full Text] [Related]